Insider Buy/Sell Details for the Healthcare Sector — July 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1441)
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
400
Price
$27.89
Total Value
$11.16K
Shares Held After
26,250
% of Holdings
1.5%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
7,100
Price
$27.31
Total Value
$193.88K
Shares Held After
26,650
% of Holdings
21.0%
HCW Biologics Inc. (HCWB)
Flowers Lee — SVP of Business Development
Shares
7,736
Price
$2.58
Total Value
$20.00K
Shares Held After
8,691
% of Holdings
89.0%
Kiniksa Pharmaceuticals International, plc (KNSA)
Cole G Bradley — Director
Shares
3,673
Price
$81.43
Total Value
$299.09K
Shares Held After
11,672
% of Holdings
23.9%
Anteris Technologies Global Corp. (AVR)
L1 Capital Pty Ltd — 10% Owner
Shares
155,505
Price
$8.04
Total Value
$1.25M
Shares Held After
7,191,947
% of Holdings
2.1%
PROTHENA CORP PUBLIC LTD CO (PRTA)
Isaacs Michael John — General Counsel&Company Sec.
Shares
8,386
Price
$8.47
Total Value
$71.06K
Shares Held After
35,745
% of Holdings
19.0%
PROTHENA CORP PUBLIC LTD CO (PRTA)
Kingston Anne Evans — Chief Strategy Officer
Shares
7,662
Price
$8.47
Total Value
$64.92K
Shares Held After
55,782
% of Holdings
12.1%
MapLight Therapeutics, Inc. (MPLT)
Catalyst4, Inc. — 10% Owner
Shares
3,000
Price
$12.63
Total Value
$37.89K
Shares Held After
19,906,689
% of Holdings
0.0%
ANI PHARMACEUTICALS INC (ANIP)
CAREY STEPHEN P. — SVP&CFO
Shares
2,850
Price
$81.36
Total Value
$231.88K
Shares Held After
174,693
% of Holdings
1.6%
AtriCure, Inc. (ATRC)
Noznesky Justin J — Chief Mktg&Strategy Officer
Shares
6,182
Price
$38.80
Total Value
$239.86K
Shares Held After
100,219
% of Holdings
5.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,240
Price
$525.46
Total Value
$651.57K
Shares Held After
324,443
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,982
Price
$524.47
Total Value
$1.04M
Shares Held After
325,683
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,318
Price
$523.62
Total Value
$690.14K
Shares Held After
327,665
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
880
Price
$522.51
Total Value
$459.81K
Shares Held After
328,983
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,270
Price
$521.32
Total Value
$662.08K
Shares Held After
329,863
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
900
Price
$520.40
Total Value
$468.36K
Shares Held After
331,133
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,112
Price
$519.29
Total Value
$577.45K
Shares Held After
332,033
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
798
Price
$518.25
Total Value
$413.56K
Shares Held After
333,145
% of Holdings
0.2%
Greenwich LifeSciences, Inc. (GLSI)
Patel Snehal — Director
Shares
700
Price
$13.10
Total Value
$9.17K
Shares Held After
5,611,402
% of Holdings
0.0%
Natera, Inc. (NTRA)
Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Shares
1,863
Price
$249.38
Total Value
$464.59K
Shares Held After
52,432
% of Holdings
3.4%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,000
Price
$0.78
Total Value
$3.90K
Shares Held After
373,885
% of Holdings
1.3%
Viking Therapeutics, Inc. (VKTX)
Mancini Marianna — Chief Operating Officer
Shares
18,217
Price
$33.47
Total Value
$609.64K
Shares Held After
422,760
% of Holdings
4.1%
Viking Therapeutics, Inc. (VKTX)
Lian Brian — Director
Shares
148,517
Price
$33.32
Total Value
$4.95M
Shares Held After
2,572,441
% of Holdings
5.5%
Viking Therapeutics, Inc. (VKTX)
ZANTE GREG — Chief Financial Officer
Shares
21,217
Price
$33.47
Total Value
$710.14K
Shares Held After
212,204
% of Holdings
9.1%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
1,600
Price
$5.00
Total Value
$8.00K
Shares Held After
393,266
% of Holdings
0.4%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
1,810
Price
$5.00
Total Value
$9.05K
Shares Held After
391,666
% of Holdings
0.5%
INTUITIVE SURGICAL INC (ISRG)
Brosius Mark — EVP&Chief Mfg and Supply Cha
Shares
28
Price
$360.21
Total Value
$10.09K
Shares Held After
1,322
% of Holdings
2.1%
Outlook Therapeutics, Inc. (OTLK)
Sukhtian Faisal Ghiath — Director
Shares
95,398
Price
$1.05
Total Value
$100.00K
Shares Held After
220,972
% of Holdings
43.2%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
5,324
Price
$42.95
Total Value
$228.67K
Shares Held After
200,000
% of Holdings
2.6%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
26,875
Price
$42.36
Total Value
$1.14M
Shares Held After
205,324
% of Holdings
11.6%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
17,801
Price
$41.34
Total Value
$735.89K
Shares Held After
232,199
% of Holdings
7.1%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
798
Price
$42.95
Total Value
$34.27K
Shares Held After
824,631
% of Holdings
0.1%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
4,031
Price
$42.36
Total Value
$170.75K
Shares Held After
825,429
% of Holdings
0.5%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
2,671
Price
$41.34
Total Value
$110.42K
Shares Held After
829,460
% of Holdings
0.3%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
14,374
Price
$42.95
Total Value
$617.36K
Shares Held After
15,255,469
% of Holdings
0.1%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
72,560
Price
$42.36
Total Value
$3.07M
Shares Held After
15,269,843
% of Holdings
0.5%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
48,066
Price
$41.34
Total Value
$1.99M
Shares Held After
15,342,403
% of Holdings
0.3%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
6,122
Price
$42.95
Total Value
$262.94K
Shares Held After
8,717,783
% of Holdings
0.1%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
30,906
Price
$42.36
Total Value
$1.31M
Shares Held After
8,723,905
% of Holdings
0.4%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
20,472
Price
$41.34
Total Value
$846.31K
Shares Held After
8,754,811
% of Holdings
0.2%
MapLight Therapeutics, Inc. (MPLT)
Catalyst4, Inc. — 10% Owner
Shares
65,137
Price
$11.69
Total Value
$761.39K
Shares Held After
19,903,689
% of Holdings
0.3%
MapLight Therapeutics, Inc. (MPLT)
Catalyst4, Inc. — 10% Owner
Shares
141,088
Price
$10.74
Total Value
$1.52M
Shares Held After
19,838,552
% of Holdings
0.7%
NEUROCRINE BIOSCIENCES INC (NBIX)
Norwalk Leslie V — Director
Shares
1,250
Price
$182.01
Total Value
$227.51K
Shares Held After
1,588
% of Holdings
44.0%
Relay Therapeutics, Inc. (RLAY)
Rahmer Peter — Cheif Corporate Development Officer
Shares
748
Price
$18.61
Total Value
$13.92K
Shares Held After
228,165
% of Holdings
0.3%
Karyopharm Therapeutics Inc. (KPTI)
Poulton Stuart — EVP, Chief Development Officer
Shares
189
Price
$7.10
Total Value
$1.34K
Shares Held After
94,632
% of Holdings
0.2%
Relay Therapeutics, Inc. (RLAY)
Bergstrom Donald A — President, R&D
Shares
2,237
Price
$18.61
Total Value
$41.63K
Shares Held After
407,660
% of Holdings
0.5%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
1,459
Price
$18.61
Total Value
$27.15K
Shares Held After
158,285
% of Holdings
0.9%
AtriCure, Inc. (ATRC)
WEHRWEIN SVEN — Director
Shares
25,000
Price
$37.84
Total Value
$946.00K
Shares Held After
40,518
% of Holdings
38.2%
AtriCure, Inc. (ATRC)
Doraiswamy Vinayak — Chief Scientific Officer
Shares
6,000
Price
$38.88
Total Value
$233.28K
Shares Held After
86,511
% of Holdings
6.5%
Greenwich LifeSciences, Inc. (GLSI)
Patel Snehal — Director
Shares
1,500
Price
$13.59
Total Value
$20.39K
Shares Held After
5,610,702
% of Holdings
0.0%
Showing 101–150 of 1441 transactions (page 3 of 29)